Risuntek Inc. (SHE:002981)
China · Delayed Price · Currency is CNY 27.01
+0.36 (1.35%)
Aug 4, 2025, 2:45 PM CST
Intra-Cellular Therapies Revenue
Risuntek had revenue of 396.90M CNY in the quarter ending March 31, 2025, with 39.33% growth. This brings the company's revenue in the last twelve months to 1.85B, up 23.52% year-over-year. In the year 2024, Risuntek had annual revenue of 1.73B with 21.24% growth.
Revenue (ttm)
1.85B
Revenue Growth
+23.52%
P/S Ratio
1.95
Revenue / Employee
394.85K
Employees
4,676
Market Cap
3.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.73B | 303.79M | 21.24% |
| Dec 31, 2023 | 1.43B | 45.02M | 3.25% |
| Jan 1, 2023 | 1.39B | 75.84M | 5.79% |
| Jan 1, 2022 | 1.31B | 404.90M | 44.75% |
| Dec 31, 2020 | 904.72M | 77.06M | 9.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Contemporary Amperex Technology | 374.13B |
| Beijing-Shanghai High-Speed Railway | 42.27B |
| China State Construction Engineering Corporation | 2,193.17B |
| S.F. Holding | 288.93B |
| AVIC Chengdu Aircraft Company | -12.42B |
| CRRC Corporation | 262.95B |
| AVIC Shenyang Aircraft Company | 39.18B |
| NARI Technology | 58.56B |